Showing results (1521-1530 of 4,218) with videos related to

Sort By:
Pageof 422
Discover Oncology|August 8, 2025
Multi-omics dissection of CPNE1 reveals its prognostic value and immune-regulatory function in liver cancerLiu Liu, He Hong, Weiwei Zhang, et al.
Discover Oncology|August 6, 2025
WGCNA and single-cell analysis reveal ferroptosis-related gene signatures for hepatocellular carcinoma prognosis and therapyCan Peng, Fujian Yan, Mingli Xu, et al.
Discover Oncology|August 2, 2025
Identification of hub genes for psoriasis and thyroid cancer using bioinformatics analysisHaiXia Shi, Yuan Guo, JuPing Chen, et al.
Discover Oncology|July 31, 2025
Exploring the liver-brain axes: insights from a bidirectional Mendelian randomization study on brain cortical structure and liver cancersQiuyu Zhu, Zhaoxuan Li, Changmin Cai, et al.
Discover Oncology|July 29, 2025
Heterogeneity of the liver cancer tumor microenvironment: mitochondrial metabolism and causal inference through Mendelian randomizationXiaping Liu, Zhang Jing, Jian Chen, et al.
Discover Oncology|July 31, 2025
Prognostic value of FDG PET/CT in special types of breast cancer with non-favorable histologyMutsumi Fujimoto, Momoko Takaya, Kanako Suzuki, et al.
Discover Oncology|July 31, 2025
Two-sample Mendelian randomization analysis of the causal association between circulating inflammatory proteins and osteosarcomaHong Tang, Na Tang, Yueling Liao, et al.
Discover Oncology|July 30, 2025
Bibliometric insights into molecular and bioinformatic research trends on ameloblastomaYoithapprabhunath Thuckanaickenpalayam Ragunathan, Ramdas Madhavan Nirmal, Supriya Kheur, et al.
Discover Oncology|November 11, 2025
Global research landscapes of ALDH2 and cancer revealed by bibliometric analysisTongtong Zhang, Xiaodong Chen, Wenjie Yu, et al.
Discover Oncology|November 11, 2025
Plasma proteins and osteosarcoma risk: causal evidence from Mendelian randomizationHanjun Ma, Ju Liao, Zonglong He, et al.
Pageof 422